Skip to main content
TTrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor.

Clinical Trials in New Hampshire

27 recruiting clinical trials across 4 cities in New Hampshire (NH). Eligibility criteria explained in plain English.

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.
27
Total Trials
27
Recruiting Now
4
Cities
20
Conditions

Recruiting Trials in New Hampshire

Clinical trial data sourced from ClinicalTrials.gov. Always consult your doctor before considering any clinical trial.

RECRUITINGPhase 3NCT01804686

A Long-term Extension Study of PCI-32765 (Ibrutinib)

The purpose of this study is to collect long-term safety and efficacy data for participants treated with ibrutinib and to provide ongoing access to ibrutinib for participants who...

Sponsor: Janssen Research & Development, LLCEnrolling: 70020 locations
Chronic Lymphocytic LeukemiaSmall Lymphocytic LymphomaMantle Cell Lymphoma+4
RECRUITINGPhase 2NCT02691923

Diagnostic Performance of Fluorescein as an Intraoperative Brain Tumor Biomarker

This clinical research will evaluate the diagnostic potential of fluorescein as visualized through an operating microscope relative to 1) contrast enhancement on co-registered...

Sponsor: David W. RobertsEnrolling: 301 location
Brain Cancer
RECRUITINGNCT02726061

Internet Based Psychological Support

The investigators have developed interactive, multimedia-intensive, computer-based treatment programs that include depression (Problem-Solving Therapy), stress management, and...

Sponsor: Dartmouth-Hitchcock Medical CenterEnrolling: 5001 location
DepressionStressConflict Resolution
RECRUITINGNCT04496687

International Spontaneous Coronary Artery Dissection (SCAD) "iSCAD" Registry

The aim of "iSCAD," the International Spontaneous Coronary Artery Dissection (SCAD) Registry, is to serve as an internationally collaborative, multicenter registry coordinated by...

Sponsor: SCAD AllianceEnrolling: 100020 locations
Spontaneous Coronary Artery Dissection
RECRUITINGPhase 1NCT04552275

The HALT Biomarker Study

The purpose of the HALT Biomarkers study are to identify a panel of circulating proteins that discriminates between patients with and without Hypo-Attenuated Leaflet Thickening...

Sponsor: Massachusetts General HospitalEnrolling: 3003 locations
Aortic StenosisHypo-attenuated Leaflet ThickeningBioprosthetic Valve Degeneration
RECRUITINGPhase 1 / Phase 2NCT04956640

Study of LY3537982 in Cancer Patients With a Specific Genetic Mutation (KRAS G12C)

The purpose of this study is to find out whether the study drug, LY3537982, is safe and effective in cancer patients who have a specific genetic mutation (KRAS G12C). Patients...

Sponsor: Eli Lilly and CompanyEnrolling: 54020 locations
Carcinoma, Non-Small-Cell LungColorectal NeoplasmsEndometrial Neoplasms+3
RECRUITINGNCT05230173

Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission

The purpose of this study is to compare the effectiveness and safety of a strategy of switching to an alternative targeted immunomodulator (TIM) therapy to treat to a target of...

Sponsor: University of California, San DiegoEnrolling: 25020 locations
Ulcerative ColitisCrohn Disease
RECRUITINGNCT05526105

Gastric US in ICU Patient

This is a case series study using gastric ultrasound in critically ill patients to quantify gastric residual volumes to compare the efficacy of different NPO protocols.

Sponsor: Dartmouth-Hitchcock Medical CenterEnrolling: 501 location
Critical IllnessSurgeryAspiration Pneumonia
RECRUITINGNCT05753748

Surveillance vs. Endoscopic Therapy for Barrett's Esophagus With Low-grade Dysplasia

The purpose of this study is to learn the best approach to treating patients with known or suspected Barrett's esophagus by comparing endoscopic surveillance to endoscopic...

Sponsor: University of Colorado, DenverEnrolling: 68020 locations
Barretts Esophagus With DysplasiaBarrett EsophagusEsophageal Adenocarcinoma
RECRUITINGNCT05776225

Pulmonary Hypertension Screening in Patients With Interstitial Lung Disease for Earlier Detection

Study GMS-PH-001 is a multicenter, open-label, non-randomized study to prospectively evaluate screening strategies of pulmonary hypertension (PH) in patients with interstitial...

Sponsor: United TherapeuticsEnrolling: 30020 locations
Interstitial Lung DiseasePulmonary Hypertension
RECRUITINGPhase 1NCT05948865

A Phase 1 Study of CPO301 in Adult Patients With Advanced or Metastatic Solid Tumors

The goal of this clinical trial is to test CPO301, a type of drug called an antibody drug conjugate in adult patients with advanced or metastatic solid tumors. The main questions...

Sponsor: Conjupro Biotherapeutics, Inc.Enrolling: 13214 locations
CancerCancer, Lung
RECRUITINGNCT05982795

Impact of Highly Effective Modulator Therapy on the Cystic Fibrosis Microbiome

The goal of this observational study is to learn about the effects of a specific cystic fibrosis therapy (Cystic Fibrosis Transmembrane Conductance Regulator Modulator Therapy) on...

Sponsor: Dartmouth-Hitchcock Medical CenterEnrolling: 301 location
Cystic Fibrosis
RECRUITINGNCT05987852

Hyperbaric Oxygen Therapy for Ulcerative Colitis (HBOT-UC)

Chronic intestinal hypoxia and accompanying mucosal inflammation is a hallmark of ulcerative colitis (UC). Hyperbaric oxygen therapy (HBOT) involves breathing 100% oxygen under...

Sponsor: Northwestern UniversityEnrolling: 12613 locations
Ulcerative Colitis
RECRUITINGPhase 1 / Phase 2NCT06362369

A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy

This study is an open-label Phase Ib (Part A) dose escalation followed by a blinded, randomized, multi cohort Phase 2a (Part B) comparison of combination vs. reference regimens....

Sponsor: 7 Hills Pharma, LLCEnrolling: 1264 locations
Advanced CancerAdvanced Solid TumorMelanoma+15
RECRUITINGPhase 3NCT06376994

Multi-Center Clean Air Randomized Controlled Trial in COPD

This is a multi-center randomized, sham-controlled clinical trial to determine the effectiveness of an air cleaner intervention aimed at improving indoor air quality on reducing...

Sponsor: Jhsph Center for Clinical TrialsEnrolling: 77011 locations
Chronic Obstructive Pulmonary Disease (COPD)
RECRUITINGNCT06425029

Self-administered ONe-of-a Kind Approach to Epilepsy Therapy Through a Web-based Music Application

This is a prospective, placebo-controlled, double-blinded randomized study of self-administered auditory intervention in a naturalistic home environment.

Sponsor: Dartmouth-Hitchcock Medical CenterEnrolling: 242 locations
EpilepsyRefractory EpilepsyMusic
RECRUITINGNCT06595420

Kidney Function in People With Cystic Fibrosis in the Era of HEMT

The purpose of this study is to find out what causes kidney disease in people with CF. The investigators will study biomarkers in the blood and urine that can either predict who...

Sponsor: University of VirginiaEnrolling: 2603 locations
Cystic Fibrosis (CF)Chronic Kidney Disease(CKD)Acute Kidney Injury
RECRUITINGNCT06735534

Repeat Ablation of Persistent Atrial Fibrillation, Including Mitral Isthmus Catheter Ablation, With the FARAPULSE...

The ReMATCH Study is a prospective, single arm, open label, multi-center, study utilizing the FARAPULSE PFA System, including the FARAWAVE and FARAPOINT PFA Catheters.

Sponsor: Boston Scientific CorporationEnrolling: 37620 locations
Persistent Atrial Fibrillation
RECRUITINGPhase 3NCT06810505

A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in...

Migraine is a disease that most often causes moderate to severe headache on one side of the head. A migraine attack is a headache that may be accompanied by throbbing, nausea,...

Sponsor: AbbVieEnrolling: 42020 locations
Chronic Migraine
RECRUITINGPhase 2NCT06815497

Telmisartan in Combination With Cytotoxic Regimens in Platinum-Resistant Ovarian Cancer

The primary study objective is to assess progression-free survival in patients with ovarian cancer receiving telmisartan plus selected standard of care chemotherapy regimens...

Sponsor: Tyler J CurielEnrolling: 332 locations
Ovarian Cancer
RECRUITINGPhase 3NCT06881784

Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)

The purpose of this study is to evaluate the safety and efficacy of a novel RAS(ON) inhibitor compared to docetaxel.

Sponsor: Revolution Medicines, Inc.Enrolling: 42020 locations
NSCLC (Non-small Cell Lung Cancer)Non-Small Cell Lung CancerNSCLC+2
RECRUITINGPhase 1NCT06920238

Use of a Generative AI (Gen-AI) Chatbot for Anxiety and Depression Among Persons With Cannabis Use

The goal of this clinical trial is to learn if Therabot-CALM (Cannabis, Anxiety, Low Mood) has acceptability among users and could work to improve the symptoms of persons with...

Sponsor: Trustees of Dartmouth CollegeEnrolling: 151 location
Cannabis Use DisorderAnxietyDepression, Anxiety+1
RECRUITINGNCT06952933

Psychological Trauma, Post-Traumatic Stress Disorder, and Resilience in Adults With Congenital Heart Disease

The purpose of this study, entitled "Psychological trauma, post-traumatic stress disorder, and resilience in adults with congenital heart disease in a large population sample", is...

Sponsor: Dartmouth-Hitchcock Medical CenterEnrolling: 10003 locations
Adult Congenital Heart DiseaseCongenital Heart DiseasePTSD
RECRUITINGPhase 2NCT07043270

24BRO681 : Alternating Gnp and mFOLFIRINOX for BR-PDAC

The purpose of this research is to study the effects and safety of alternating neoadjuvant chemotherapy on borderline resectable pancreatic cancer.

Sponsor: Dartmouth-Hitchcock Medical CenterEnrolling: 351 location
Pancreas Adenocarcinoma
RECRUITINGPhase 2 / Phase 3NCT07063745

A Study to Compare the Combination of BMS-986504 With Pembrolizumab and Chemotherapy Versus Placebo Plus Pembrolizumab...

The purpose of this study is to compare the clinical benefit of the combination of BMS-986504 (a selective MTA-cooperative inhibitor of PRMT5) plus pembrolizumab and chemotherapy...

Sponsor: Bristol-Myers SquibbEnrolling: 59020 locations
Metastatic Non-small Cell Lung Cancer With MTAP Deletion
RECRUITINGNCT07089420

ALPCO/Calprotectin CLIA Assay: Expected Values of Calprotectin in Healthy Subjects

This study is evaluating the levels of calprotectin, a protein found in stool, in healthy adults. Calprotectin is a marker of inflammation in the intestines and can help doctors...

Sponsor: American Laboratory Products CompanyEnrolling: 1201 location
IBD (Inflammatory Bowel Disease)IBS - Irritable Bowel SyndromeCrohn Disease (CD)+1
RECRUITINGNCT07368647

Chronic Radiation Cystitis and Effect of Hyperbaric Oxygen Therapy on Patient Reported Outcomes and Urine Inflammatory...

Collection of urine, blood, and tissue samples from patients undergoing hyperbaric oxygen therapy

Sponsor: Rachel A. MosesEnrolling: 1001 location
Radiation CystitisUrinary Tract Infection (Diagnosis)

Browse Trials by State

Frequently Asked Questions

There are currently 27 clinical trials actively recruiting participants in New Hampshire. These span all phases from early-stage Phase 1 to late-stage Phase 3 trials, across 20+ conditions.

The top conditions with recruiting trials in New Hampshire include Ulcerative Colitis, NSCLC, Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Mantle Cell Lymphoma. Each has multiple active trials across research centers in the state.

Major trial sites in New Hampshire include Lebanon, Manchester, Nashua, Salem. Most large academic medical centers and research hospitals serve as trial sites.

Review the trial listings on this page and check the eligibility criteria — we translate them into plain English. When you find a trial that fits, talk to your doctor about whether it's right for you, then contact the trial team directly using the information on the trial page.

Sources: ClinicalTrials.gov
Last updated:

Trial data sourced from the ClinicalTrials.gov API. Location data reflects registered trial sites. This site does not provide medical advice.